Cannatrek shareholders approve merger with Little Green Pharma by Steve Jones April 10, 2026April 10, 2026 Cannatrek shareholders have overwhelmingly approved the firm’s merger with Little Green Pharma. All but four per […]
TGA still investigating Cannatrek, merger document states, as dates set for key shareholder votes by Steve Jones March 26, 2026March 26, 2026
Australian exports to Germany triple as imports top 200 tonnes by Adam Sheldon March 18, 2026March 18, 2026
News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026June 8, 2026
Cannatrek ‘evolution’ key to merger, says LGP managing director by Adam Sheldon February 3, 2026February 5, 2026
European growth helps LGP report record quarter of revenue by Steve Jones January 30, 2026February 3, 2026
French medicinal cannabis transition stalls as pilot extended into 2026 by Adam Sheldon January 27, 2026January 27, 2026
Cannatrek deal driven by ‘critical’ need to maintain margins, says LGP boss by Steve Jones January 19, 2026January 19, 2026
Cannatrek in reverse takeover of LGP as firms announce ‘transformational merger’ by Steve Jones January 14, 2026January 15, 2026
